As CD39 is recognised as a useful marker for identifying tumour-reactive CD8 + T cells, we individually analysed the usage of 24 TCR-Vβ families in pleural CD39 + CD8 + T cells (Fig. 5A). The gene discussed is ENTPD1; the disease is neoplasm.